Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2014
03/05/2014EP2702054A2 Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use
03/05/2014EP2702053A2 Novel rock inhibitors
03/05/2014EP2702052A1 17alpha-hydroxylase/c17,20-lyase inhibitors
03/05/2014EP2702051A1 Ethynyl derivatives as positive allosteric modulators of the mglur5
03/05/2014EP2702050A1 Pyrazolidin-3-one derivatives
03/05/2014EP2702043A1 Inhibitors of inducible form of 6-phosphofructose-2-kinase
03/05/2014EP2702042A1 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators
03/05/2014EP2702041A1 Alkaloid ester and carbamate derivatives and medicinal compositions thereof
03/05/2014EP2702037A1 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease
03/05/2014EP2702033A1 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
03/05/2014EP2702030A1 Compositions and methods
03/05/2014EP2701745A1 Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
03/05/2014EP2701744A1 Combination therapy
03/05/2014EP2701739A1 Tolerogenic synthetic nanocarriers to reduce antibody responses
03/05/2014EP2701738A2 Tolerogenic synthetic nanocarriers for inducing regulatory b cells
03/05/2014EP2701737A1 Tolerogenic synthetic nanocarriers for allergy therapy
03/05/2014EP2701731A1 Intravascular delivery of nanoparticle compositions and uses thereof
03/05/2014EP2701724A1 Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinocetan (folfiri)
03/05/2014EP2701719A1 Method for treatment of macular degeneration by modulating p2y12 or p2x7 receptors
03/05/2014EP2701715A2 Prophylaxis and treatment of enteropathogenic bacterial infection
03/05/2014EP2701714A1 Method for isolation of polysaccharides
03/05/2014EP2701713A1 Modulation of apolipoprotein ciii (apociii) expression
03/05/2014EP2701712A1 Use of uridine and deoxyuridine to treat folate-responsive pathologies
03/05/2014EP2701711A2 Acute cognitive and mood effects of plant polysaccharides in adult human subjects
03/05/2014EP2701710A1 Anti-inflammatory composition for the intestine including maltitol
03/05/2014EP2701709A1 Method for modulating ion transporter
03/05/2014EP2701708A2 Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
03/05/2014EP2701707A1 Method of treating dyskinesia
03/05/2014EP2701706A2 Tolerogenic synthetic nanocarriers
03/05/2014EP2701705A2 Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
03/05/2014EP2701704A2 Methods of administering anatabine to treat autism spectrum disorders and seizure disorders
03/05/2014EP2701703A1 Combination of a phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitor
03/05/2014EP2701702A2 Oxymetazoline for the treatment of ano-rectal disorders
03/05/2014EP2701701A1 Methods and compositions using pde4 inhibitors for the treatment and management of autoimmune and inflammatory diseases
03/05/2014EP2701700A1 Drug therapy to inhibit chemotherapy-induced adverse effects and related pharmaceutical compositions, diagnostics, screening techniques and kits
03/05/2014EP2701699A1 Inhibitors of histone deacetylase
03/05/2014EP2701698A2 Disorders implicating pufa oxidation
03/05/2014EP2701697A2 Oxidative retinal diseases
03/05/2014EP2701696A2 Impaired energy processing disorders and mitochondrial deficiency
03/05/2014EP2701695A2 Neurodegenerative disorders and muscle diseases implicating pufas
03/05/2014EP2701694A1 Methods of treating hemoglobinopathies
03/05/2014EP2701693A1 Tapentadol for preventing and treating depression and anxiety
03/05/2014EP2701692A1 Methods and pharmaceutical compositions for the treatment of hormone-refractory prostate cancers
03/05/2014EP2701691A1 Composition for prevention and treatment of rheumatoid arthritis
03/05/2014EP2701690A1 Method of treating lymphoma using pyridopyrimidinone inhibitors of pi3k/mtor
03/05/2014EP2701687A1 Risperidone sustained release microsphere composition
03/05/2014EP2701683A1 Administration of iloprost as aerosol bolus
03/05/2014EP2701682A1 Solvent cast film sustained release latanoprost implant
03/05/2014EP2701681A1 Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat
03/05/2014EP2701680A1 Sustained release latanoprost implant
03/05/2014EP2701668A1 Layer processing for pharmaceuticals
03/05/2014EP2701512A1 Aldosterone synthase inhibitors
03/05/2014EP2701510A1 Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
03/05/2014EP2701509A1 Fatty acid guanidine and salicylate guanidine derivatives and their uses
03/05/2014EP2701508A1 Production and delivery of a stable collagen
03/05/2014EP2701507A1 Heterocyclic compounds as b-raf inhibitors for treatment of cancer
03/05/2014EP2701504A1 Derivatives of sulindac, use thereof and preparation thereof
03/05/2014DE212011100215U1 Ernährungsprodukt, umfassend ein Biguanid Nutritional product comprising a biguanide
03/05/2014CN203458604U Toxicity removal dressing
03/05/2014CN203458603U Release retardant liquid filling device for nifedipine sustained-release tablets
03/05/2014CN203458591U Cervical vertebra health-care sachet
03/05/2014CN1882590B Fused heterocyclic compounds as serotonin receptor modulators
03/05/2014CN103620033A SEMA5B peptides and vaccines including the same
03/05/2014CN103619867A Process for the production of estetrol intermediates
03/05/2014CN103619865A Certain chemical entities, compositions, and methods
03/05/2014CN103619862A Glycoside derivatives and uses thereof
03/05/2014CN103619853A Cephem compound having pyridinium group
03/05/2014CN103619852A Polymorph of rifaximin and process for the preparation thereof
03/05/2014CN103619846A 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives
03/05/2014CN103619845A Fluoroalkyl-substituted pyrazolopyridines and use thereof
03/05/2014CN103619843A 1,6-diazabicyclo[3,2,1]octan-7-one derivatives and use thereof in treating bacterial infections
03/05/2014CN103619842A Crystal of pyrroloquinolinequinone disodium salt, and method for producing same
03/05/2014CN103619841A Heteroaryl compounds and methods of use thereof
03/05/2014CN103619840A Polymorphs of (S)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol-2-yl}-amide
03/05/2014CN103619838A Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists
03/05/2014CN103619837A Fatty acid amide hydrolase inhibitors for treating pain
03/05/2014CN103619836A Antimicrobial/adjuvant compounds and methods
03/05/2014CN103619835A Novel pyrimidine derivatives
03/05/2014CN103619834A Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, their preparation and their use as P2Y12 antagonists
03/05/2014CN103619828A Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
03/05/2014CN103619825A 1, 2, 4-thiadiazol-5-ylpiperazine derivatives useful in the treatment neurodegenerative diseases
03/05/2014CN103619824A Amide compound and pharmaceutical application therefor
03/05/2014CN103619823A Crystals of glycine derivative and pharmaceutical use thereof
03/05/2014CN103619820A Tetrahydroquinoline derivatives useful as bromodomain inhibitors
03/05/2014CN103619819A Method for producing fine particles of aripiprazole anhydride crystals B
03/05/2014CN103619817A Novel bicyclic nitrogen containing heteroaryl TGR5 receptor modulators
03/05/2014CN103619814A Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome
03/05/2014CN103619805A Benzylamine derivative
03/05/2014CN103619403A Applicator system for applying a viscous liquid to the human skin
03/05/2014CN103619355A Apoptosis-inducing agent
03/05/2014CN103619354A Antipruritic agent
03/05/2014CN103619341A Method of inhibiting harmful microorganisms and barrier-forming composition therefor
03/05/2014CN103619340A Use of uridine and deoxyuridine to treat folate-responsive pathologies
03/05/2014CN103619339A Tablet containing limaprost and ss-cyclodextrin
03/05/2014CN103619338A Intranasal benzodiazepine pharmaceutical compositions
03/05/2014CN103619337A Novel cancer therapies and methods
03/05/2014CN103619336A Sanglifehrin derivatives and methods for their production
03/05/2014CN103619335A Fast dissolving azaperone granulate formulation
03/05/2014CN103619334A Thiazolidine derivatives and therapeutic use thereof
03/05/2014CN103619332A Acadesine derivatives, products and compositions including same, therapeutic uses thereof, and methods for synthesizing same
1 ... 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 ... 7860